RSV & Norovirus surge, Green Country ER's filling up, wait times increasing "Respiratory illness in particular is spreading," said Dr. Peyton Holden, including the flu with symptoms including ...
GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...
Watch Ravijyot Saggu discuss the 2024 ERS guideline on managing severe respiratory disease in adults at our Clinical Excellence event.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback